fluorodeoxyglucose f18 has been researched along with Adenomatous Polyposis Coli in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Beyhan, E; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö; Yarikkaya, E | 1 |
Cai, L; Chen, Y; Shao, F; Zhang, J | 1 |
Bhandari, S; Clark, SK; Goh, V; Sanghera, B; Sinha, A; Sonoda, L; Taylor, NJ; Wong, WL | 1 |
Drenth, JP; Friederich, P; Nagengast, FM; Oyen, WJ; van Goor, H; van Kouwen, MC; van Krieken, JH | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and Adenomatous Polyposis Coli
Article | Year |
---|---|
Role of 68 Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis.
Topics: Adenomatous Polyposis Coli; Colonic Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Diffuse Intense Intestinal FDG Activity in a Patient With Familial Adenomatous Polyposis.
Topics: Adenomatous Polyposis Coli; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2019 |
Can combined 18F-FDG-PET and dynamic contrast-enhanced MRI predict behavior of desmoid tumors in patients with familial adenomatous polyposis?
Topics: Adenomatous Polyposis Coli; Adult; Analysis of Variance; Area Under Curve; Contrast Media; Female; Fibromatosis, Abdominal; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2012 |
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
Topics: Adenomatous Polyposis Coli; Adult; Colonic Neoplasms; Delivery of Health Care; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |